Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzu mab-based therapy for metastatic breast cancer

被引：6

作者：

Altundag, K

Altundag, O

Atik, MA

Morandi, P

Gunduz, M

机构：

[1] Hacettepe Univ, Dept Med Oncol, Fac Med, Ankara, Turkey

[2] Baylor Coll Med, Dept Pulm & Crit Care Med, Houston, TX 77030 USA

[3] S Bortolo Gen Hosp, Dept Med Oncol, Vicenza, Italy

[4] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med & Dent, Okayama, Japan

来源：

BREAST | 2005年 / 14卷 / 05期

关键词：

D O I：

10.1016/j.breast.2004.08.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：425 / 425

页数：1

共 8 条

[1]

Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab [J].

Baculi, RH ;

Suki, S ;

Nisbett, J ;

Leeds, N ;

Groves, M .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3297-3298

[2]

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].

Bendell, JC ;

Domchek, SM ;

Burstein, HJ ;

Harris, L ;

Younger, J ;

Kuter, I ;

Bunnell, C ;

Rue, M ;

Gelman, R ;

Winer, E .

CANCER, 2003, 97 (12) :2972-2977

[3]

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].

Clayton, AJ ;

Danson, S ;

Jolly, S ;

Ryder, WDJ ;

Burt, PA ;

Stewart, AL ;

Wilkinson, PM ;

Welch, RS ;

Magee, B ;

Wilson, G ;

Howell, A ;

Wardley, AM .

BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643

[4]

Chemotherapy for breast cancer brain metastases [J].

Fenner, MH ;

Possinger, K .

ONKOLOGIE, 2002, 25 (05) :474-479

[5]

HER2 in brain metastases:: issues of concordance, survival, and treatment [J].

Fuchs, IB ;

Loebbecke, M ;

Buhler, H ;

Stoltenburg-Didinger, G ;

Heine, B ;

Lichtenegger, W ;

Schaller, G .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :4130-4133

[6]

Liang K, 2003, MOL CANCER THER, V2, P1113

[7]

The role of chemotherapy in brain metastases [J].

van den Bent, MJ .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (15) :2114-2120

[8]

van Vulpen M, 2002, ONCOL REP, V9, P683

← 1 →